Atea Pharmaceuticals Files 2024 10-K
Ticker: AVIR · Form: 10-K · Filed: Mar 6, 2025 · CIK: 1593899
| Field | Detail |
|---|---|
| Company | Atea Pharmaceuticals, Inc. (AVIR) |
| Form Type | 10-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Atea Pharma's 2024 10-K is in. Full year financials and biz details out now.
AI Summary
Atea Pharmaceuticals, Inc. filed its 2024 10-K on March 6, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in Boston, MA, operates in the pharmaceutical preparations sector. Key financial data and operational details for the fiscal year are presented in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Atea Pharmaceuticals' financial performance, strategic initiatives, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Atea Pharmaceuticals is subject to significant risks including regulatory hurdles, clinical trial outcomes, and market competition.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the 10-K)
- 20250306 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Atea Pharmaceuticals, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 20250306 (date) — Filing date
- Boston, MA (location) — Company headquarters
FAQ
What is the primary business of Atea Pharmaceuticals, Inc.?
Atea Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.
When did Atea Pharmaceuticals, Inc. file its 10-K report?
Atea Pharmaceuticals, Inc. filed its 10-K report on March 6, 2025.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Where is Atea Pharmaceuticals, Inc. headquartered?
Atea Pharmaceuticals, Inc. is headquartered at 225 Franklin Street, Suite 2100, Boston, MA 02110.
What is the SEC file number for Atea Pharmaceuticals, Inc.?
The SEC file number for Atea Pharmaceuticals, Inc. is 001-39661.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 6, 2025 regarding Atea Pharmaceuticals, Inc. (AVIR).